Luissint AC , Nusrat A , Parkos CA .

DK055679 NIDDK NIH HHS , DK059888 NIDDK NIH HHS , DK061379 NIDDK NIH HHS , DK064399 NIDDK NIH HHS , DK072564 NIDDK NIH HHS , R01 DK079392 NIDDK NIH HHS , R29 DK055679 NIDDK NIH HHS , DK079392 NIDDK NIH HHS , R01 DK072564 NIDDK NIH HHS , R24 DK064399 NIDDK NIH HHS , R01 DK055679 NIDDK NIH HHS , R01 DK061379 NIDDK NIH HHS , R01 DK059888 NIDDK NIH HHS

Anderson, Physiology and function of the tight junction. 2009, Pubmed

Anderson, Physiology and function of the tight junction. 2009, Pubmed
Arrate, Cloning of human junctional adhesion molecule 3 (JAM3) and its identification as the JAM2 counter-receptor. 2001, Pubmed
Artis, Epithelial-cell recognition of commensal bacteria and maintenance of immune homeostasis in the gut. 2008, Pubmed
Aurrand-Lions, Junctional adhesion molecule-C regulates the early influx of leukocytes into tissues during inflammation. 2005, Pubmed
Aurrand-Lions, JAM-2, a novel immunoglobulin superfamily molecule, expressed by endothelial and lymphatic cells. 2001, Pubmed
Aurrand-Lions, Heterogeneity of endothelial junctions is reflected by differential expression and specific subcellular localization of the three JAM family members. 2001, Pubmed , Xenbase
Bazzoni, Interaction of junctional adhesion molecule with the tight junction components ZO-1, cingulin, and occludin. 2000, Pubmed
Bazzoni, Pathobiology of junctional adhesion molecules. 2011, Pubmed
Bergelson, Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. 1997, Pubmed
Betanzos, Evidence for cross-reactivity of JAM-C antibodies: implications for cellular localization studies. 2009, Pubmed
Blake, Neutrophils migrate across intestinal epithelium using beta2 integrin (CD11b/CD18)-independent mechanisms. 2004, Pubmed
Bradfield, JAM family and related proteins in leukocyte migration (Vestweber series). 2007, Pubmed
Bradfield, JAM-C regulates unidirectional monocyte transendothelial migration in inflammation. 2007, Pubmed
Brannigan, Neutrophil apoptosis is delayed in patients with inflammatory bowel disease. 2000, Pubmed
Brazil, The role of polymorphonuclear leukocyte trafficking in the perpetuation of inflammation during inflammatory bowel disease. 2013, Pubmed
Brazil, Neutrophil migration across intestinal epithelium: evidence for a role of CD44 in regulating detachment of migrating cells from the luminal surface. 2010, Pubmed
Bruewer, Interferon-gamma induces internalization of epithelial tight junction proteins via a macropinocytosis-like process. 2005, Pubmed
Bruewer, Proinflammatory cytokines disrupt epithelial barrier function by apoptosis-independent mechanisms. 2003, Pubmed
Byrne, rHuKGF ameliorates symptoms in DSS and CD4(+)CD45RB(Hi) T cell transfer mouse models of inflammatory bowel disease. 2002, Pubmed
Capaldo, Cytokine regulation of tight junctions. 2009, Pubmed
Carson, Expression of the coxsackievirus and adenovirus receptor in cultured human umbilical vein endothelial cells: regulation in response to cell density. 1999, Pubmed
Cera, JAM-A promotes neutrophil chemotaxis by controlling integrin internalization and recycling. 2009, Pubmed
Cera, Increased DC trafficking to lymph nodes and contact hypersensitivity in junctional adhesion molecule-A-deficient mice. 2004, Pubmed
Cesaro, Differential expression and regulation of ADAM17 and TIMP3 in acute inflamed intestinal epithelia. 2009, Pubmed
Chavakis, The junctional adhesion molecule-C promotes neutrophil transendothelial migration in vitro and in vivo. 2004, Pubmed
Chen, Protection of the intestinal mucosa by intraepithelial gamma delta T cells. 2002, Pubmed
Chiba, Hepatocyte nuclear factor (HNF)-4alpha triggers formation of functional tight junctions and establishment of polarized epithelial morphology in F9 embryonal carcinoma cells. 2003, Pubmed
Chin, Pathobiology of neutrophil transepithelial migration: implications in mediating epithelial injury. 2007, Pubmed
Clayburgh, Epithelial myosin light chain kinase-dependent barrier dysfunction mediates T cell activation-induced diarrhea in vivo. 2005, Pubmed
Cohen, The coxsackievirus and adenovirus receptor is a transmembrane component of the tight junction. 2001, Pubmed
Colgan, Lipoxin A4 modulates transmigration of human neutrophils across intestinal epithelial monolayers. 1993, Pubmed
Colom, Schwann cell-specific JAM-C-deficient mice reveal novel expression and functions for JAM-C in peripheral nerves. 2012, Pubmed
Corada, Junctional adhesion molecule-A-deficient polymorphonuclear cells show reduced diapedesis in peritonitis and heart ischemia-reperfusion injury. 2005, Pubmed
Coyne, The coxsackievirus and adenovirus receptor interacts with the multi-PDZ domain protein-1 (MUPP-1) within the tight junction. 2004, Pubmed
Cunningham, A novel protein with homology to the junctional adhesion molecule. Characterization of leukocyte interactions. 2000, Pubmed
Cunningham, JAM2 interacts with alpha4beta1. Facilitation by JAM3. 2002, Pubmed
Darsigny, Loss of hepatocyte-nuclear-factor-4alpha affects colonic ion transport and causes chronic inflammation resembling inflammatory bowel disease in mice. 2009, Pubmed
Dejana, Endothelial cell-cell junctions: happy together. 2004, Pubmed
Del Maschio, Leukocyte recruitment in the cerebrospinal fluid of mice with experimental meningitis is inhibited by an antibody to junctional adhesion molecule (JAM). 1999, Pubmed
Ebnet, Junctional adhesion molecule interacts with the PDZ domain-containing proteins AF-6 and ZO-1. 2000, Pubmed
Ebnet, The cell polarity protein ASIP/PAR-3 directly associates with junctional adhesion molecule (JAM). 2001, Pubmed
Ebnet, The junctional adhesion molecule (JAM) family members JAM-2 and JAM-3 associate with the cell polarity protein PAR-3: a possible role for JAMs in endothelial cell polarity. 2003, Pubmed
Ebnet, Junctional adhesion molecules (JAMs): more molecules with dual functions? 2004, Pubmed
Eguchi, Identification of adipocyte adhesion molecule (ACAM), a novel CTX gene family, implicated in adipocyte maturation and development of obesity. 2005, Pubmed , Xenbase
Fais, Interferon expression in Crohn's disease patients: increased interferon-gamma and -alpha mRNA in the intestinal lamina propria mononuclear cells. 1994, Pubmed
Fanning, The tight junction protein ZO-1 establishes a link between the transmembrane protein occludin and the actin cytoskeleton. 1998, Pubmed
Fournier, The role of neutrophils during intestinal inflammation. 2012, Pubmed
Fraemohs, The functional interaction of the beta 2 integrin lymphocyte function-associated antigen-1 with junctional adhesion molecule-A is mediated by the I domain. 2004, Pubmed
Furuse, A single gene product, claudin-1 or -2, reconstitutes tight junction strands and recruits occludin in fibroblasts. 1998, Pubmed
Furuse, Occludin: a novel integral membrane protein localizing at tight junctions. 1993, Pubmed
Fuse, Junctional adhesion molecule-C promotes metastatic potential of HT1080 human fibrosarcoma. 2007, Pubmed
Gassler, Inflammatory bowel disease is associated with changes of enterocytic junctions. 2001, Pubmed
Ginzberg, Neutrophil-mediated epithelial injury during transmigration: role of elastase. 2001, Pubmed
Gliki, Spermatid differentiation requires the assembly of a cell polarity complex downstream of junctional adhesion molecule-C. 2004, Pubmed
Guo, Role of junctional adhesion molecule-like protein in mediating monocyte transendothelial migration. 2009, Pubmed
Hamazaki, Multi-PDZ domain protein 1 (MUPP1) is concentrated at tight junctions through its possible interaction with claudin-1 and junctional adhesion molecule. 2002, Pubmed
Hara, Endothelial cell-selective adhesion molecule regulates albuminuria in diabetic nephropathy. 2009, Pubmed
Hawkins, Leukocyte adhesion deficiency: clinical and postmortem observations. 1992, Pubmed
Heit, An intracellular signaling hierarchy determines direction of migration in opposing chemotactic gradients. 2002, Pubmed
Hirabayashi, JAM4, a junctional cell adhesion molecule interacting with a tight junction protein, MAGI-1. 2003, Pubmed
Hirata Ki, Cloning of an immunoglobulin family adhesion molecule selectively expressed by endothelial cells. 2001, Pubmed
Hooper, Immune adaptations that maintain homeostasis with the intestinal microbiota. 2010, Pubmed
Huang, Infection of human intestinal epithelial cells with invasive bacteria upregulates apical intercellular adhesion molecule-1 (ICAM)-1) expression and neutrophil adhesion. 1996, Pubmed
Hussain, CAR modulates E-cadherin dynamics in the presence of adenovirus type 5. 2011, Pubmed
Iden, aPKC phosphorylates JAM-A at Ser285 to promote cell contact maturation and tight junction formation. 2012, Pubmed
Imhof, Pulmonary dysfunction and impaired granulocyte homeostasis result in poor survival of Jam-C-deficient mice. 2007, Pubmed
Inoue, Endothelial cell-selective adhesion molecule modulates atherosclerosis through plaque angiogenesis and monocyte-endothelial interaction. 2010, Pubmed
Ishida, Targeted disruption of endothelial cell-selective adhesion molecule inhibits angiogenic processes in vitro and in vivo. 2003, Pubmed
Itoh, Direct binding of three tight junction-associated MAGUKs, ZO-1, ZO-2, and ZO-3, with the COOH termini of claudins. 1999, Pubmed
Itoh, Junctional adhesion molecule (JAM) binds to PAR-3: a possible mechanism for the recruitment of PAR-3 to tight junctions. 2001, Pubmed
Ivanov, Cytoskeletal regulation of epithelial barrier function during inflammation. 2010, Pubmed
Johnson-Léger, Junctional adhesion molecule-2 (JAM-2) promotes lymphocyte transendothelial migration. 2002, Pubmed
Khandoga, Junctional adhesion molecule-A deficiency increases hepatic ischemia-reperfusion injury despite reduction of neutrophil transendothelial migration. 2005, Pubmed
Khandoga, Leukocyte transmigration in inflamed liver: A role for endothelial cell-selective adhesion molecule. 2009, Pubmed
Khounlotham, Compromised intestinal epithelial barrier induces adaptive immune compensation that protects from colitis. 2012, Pubmed
Koenen, Regulated release and functional modulation of junctional adhesion molecule A by disintegrin metalloproteinases. 2009, Pubmed
Korn, Expression of the coxsackievirus- and adenovirus receptor in gastrointestinal cancer correlates with tumor differentiation. 2006, Pubmed
Kostrewa, X-ray structure of junctional adhesion molecule: structural basis for homophilic adhesion via a novel dimerization motif. 2001, Pubmed
Koval, Claudins--key pieces in the tight junction puzzle. 2006, Pubmed
Kucharzik, Neutrophil transmigration in inflammatory bowel disease is associated with differential expression of epithelial intercellular junction proteins. 2001, Pubmed
Lamagna, Dual interaction of JAM-C with JAM-B and alpha(M)beta2 integrin: function in junctional complexes and leukocyte adhesion. 2005, Pubmed
Laukoetter, JAM-A regulates permeability and inflammation in the intestine in vivo. 2007, Pubmed
Lawrence, Antiadhesive role of apical decay-accelerating factor (CD55) in human neutrophil transmigration across mucosal epithelia. 2003, Pubmed
Lee, The role of cis dimerization of signal regulatory protein alpha (SIRPalpha) in binding to CD47. 2010, Pubmed
Ley, Getting to the site of inflammation: the leukocyte adhesion cascade updated. 2007, Pubmed
Liang, Characterization of huJAM: evidence for involvement in cell-cell contact and tight junction regulation. 2000, Pubmed
Liang, Vascular endothelial-junctional adhesion molecule (VE-JAM)/JAM 2 interacts with T, NK, and dendritic cells through JAM 3. 2002, Pubmed
Liu, Human junction adhesion molecule regulates tight junction resealing in epithelia. 2000, Pubmed
Liu, The role of CD47 in neutrophil transmigration. Increased rate of migration correlates with increased cell surface expression of CD47. 2001, Pubmed
Ludwig, Junctional adhesion molecules (JAM)-B and -C contribute to leukocyte extravasation to the skin and mediate cutaneous inflammation. 2005, Pubmed
Ludwig, Junctional adhesion molecule (JAM)-B supports lymphocyte rolling and adhesion through interaction with alpha4beta1 integrin. 2009, Pubmed
Luissint, JAM-L-mediated leukocyte adhesion to endothelial cells is regulated in cis by alpha4beta1 integrin activation. 2008, Pubmed
MacDonald, Tumour necrosis factor-alpha and interferon-gamma production measured at the single cell level in normal and inflamed human intestine. 1990, Pubmed
Malergue, A novel immunoglobulin superfamily junctional molecule expressed by antigen presenting cells, endothelial cells and platelets. 1998, Pubmed
Mandell, Junctional adhesion molecule 1 regulates epithelial cell morphology through effects on beta1 integrins and Rap1 activity. 2005, Pubmed
Mandell, Involvement of the junctional adhesion molecule-1 (JAM1) homodimer interface in regulation of epithelial barrier function. 2004, Pubmed
Mandell, Expression of JAM-A in the human corneal endothelium and retinal pigment epithelium: localization and evidence for role in barrier function. 2007, Pubmed
Mandicourt, JAM-C regulates tight junctions and integrin-mediated cell adhesion and migration. 2007, Pubmed
Martinez-Estrada, Association of junctional adhesion molecule with calcium/calmodulin-dependent serine protein kinase (CASK/LIN-2) in human epithelial caco-2 cells. 2001, Pubmed
Martìn-Padura, Junctional adhesion molecule, a novel member of the immunoglobulin superfamily that distributes at intercellular junctions and modulates monocyte transmigration. 1998, Pubmed
McSherry, JAM-A expression positively correlates with poor prognosis in breast cancer patients. 2009, Pubmed
Mirza, Essential role of the coxsackie- and adenovirus receptor (CAR) in development of the lymphatic system in mice. 2012, Pubmed
Mirza, Coxsackievirus and adenovirus receptor (CAR) is expressed in male germ cells and forms a complex with the differentiation factor JAM-C in mouse testis. 2006, Pubmed
Miyata, Regulation by afadin of cyclical activation and inactivation of Rap1, Rac1, and RhoA small G proteins at leading edges of moving NIH3T3 cells. 2009, Pubmed
Monteiro, JAM-A associates with ZO-2, afadin, and PDZ-GEF1 to activate Rap2c and regulate epithelial barrier function. 2013, Pubmed
Moog-Lutz, JAML, a novel protein with characteristics of a junctional adhesion molecule, is induced during differentiation of myeloid leukemia cells. 2003, Pubmed
Morris, Junctional Adhesion Molecules (JAMs) are differentially expressed in fibroblasts and co-localize with ZO-1 to adherens-like junctions. 2006, Pubmed
Morton, CAR regulates epithelial cell junction stability through control of E-cadherin trafficking. 2013, Pubmed
Murch, Location of tumour necrosis factor alpha by immunohistochemistry in chronic inflammatory bowel disease. 1993, Pubmed
Nagamatsu, A CTX family cell adhesion molecule, JAM4, is expressed in stem cell and progenitor cell populations of both male germ cell and hematopoietic cell lineages. 2006, Pubmed
Naik, Junctional adhesion molecule-A-induced endothelial cell migration on vitronectin is integrin alpha v beta 3 specific. 2006, Pubmed
Naik, Attenuation of junctional adhesion molecule-A is a contributing factor for breast cancer cell invasion. 2008, Pubmed
Naik, Signaling through JAM-1 and alphavbeta3 is required for the angiogenic action of bFGF: dissociation of the JAM-1 and alphavbeta3 complex. 2003, Pubmed
Naik, Junctional adhesion molecules in angiogenesis. 2008, Pubmed
Nasdala, A transmembrane tight junction protein selectively expressed on endothelial cells and platelets. 2002, Pubmed
Nash, Effects of polymorphonuclear leukocyte transmigration on the barrier function of cultured intestinal epithelial monolayers. 1987, Pubmed
Nava, JAM-A regulates epithelial proliferation through Akt/β-catenin signalling. 2011, Pubmed
Nomme, The Src homology 3 domain is required for junctional adhesion molecule binding to the third PDZ domain of the scaffolding protein ZO-1. 2011, Pubmed
Nusrat, Neutrophil migration across model intestinal epithelia: monolayer disruption and subsequent events in epithelial repair. 1997, Pubmed
Okegawa, The mechanism of the growth-inhibitory effect of coxsackie and adenovirus receptor (CAR) on human bladder cancer: a functional analysis of car protein structure. 2001, Pubmed
Orlova, Junctional adhesion molecule-C regulates vascular endothelial permeability by modulating VE-cadherin-mediated cell-cell contacts. 2006, Pubmed
Ostermann, JAM-1 is a ligand of the beta(2) integrin LFA-1 involved in transendothelial migration of leukocytes. 2002, Pubmed
Ozaki, Cutting edge: combined treatment of TNF-alpha and IFN-gamma causes redistribution of junctional adhesion molecule in human endothelial cells. 1999, Pubmed
Palmeri, Vascular endothelial junction-associated molecule, a novel member of the immunoglobulin superfamily, is localized to intercellular boundaries of endothelial cells. 2000, Pubmed
Parkos, CD47 mediates post-adhesive events required for neutrophil migration across polarized intestinal epithelia. 1996, Pubmed
Parkos, Expression and polarization of intercellular adhesion molecule-1 on human intestinal epithelia: consequences for CD11b/CD18-mediated interactions with neutrophils. 1996, Pubmed
Parkos, Neutrophil migration across a cultured intestinal epithelium. Dependence on a CD11b/CD18-mediated event and enhanced efficiency in physiological direction. 1991, Pubmed
Patzke, The coxsackievirus-adenovirus receptor reveals complex homophilic and heterophilic interactions on neural cells. 2010, Pubmed
Pazirandeh, Multiple phenotypes in adult mice following inactivation of the Coxsackievirus and Adenovirus Receptor (Car) gene. 2011, Pubmed
Poritz, Tumor necrosis factor alpha disrupts tight junction assembly. 2004, Pubmed
Praetor, Genetic deletion of JAM-C reveals a role in myeloid progenitor generation. 2009, Pubmed
Prota, Crystal structure of human junctional adhesion molecule 1: implications for reovirus binding. 2003, Pubmed
Rabquer, Junctional adhesion molecule-C is a soluble mediator of angiogenesis. 2010, Pubmed
Raddatz, Quantitative measurement of cytokine mRNA in inflammatory bowel disease: relation to clinical and endoscopic activity and outcome. 2005, Pubmed
Raschperger, CLMP, a novel member of the CTX family and a new component of epithelial tight junctions. 2004, Pubmed
Raschperger, The coxsackie- and adenovirus receptor (CAR) is an in vivo marker for epithelial tight junctions, with a potential role in regulating permeability and tissue homeostasis. 2006, Pubmed
Rehder, Junctional adhesion molecule-a participates in the formation of apico-basal polarity through different domains. 2006, Pubmed
Saitou, Complex phenotype of mice lacking occludin, a component of tight junction strands. 2000, Pubmed
Sakaguchi, Putative "stemness" gene jam-B is not required for maintenance of stem cell state in embryonic, neural, or hematopoietic stem cells. 2006, Pubmed
Santoso, The junctional adhesion molecule 3 (JAM-3) on human platelets is a counterreceptor for the leukocyte integrin Mac-1. 2002, Pubmed
Satohisa, Behavior of tight-junction, adherens-junction and cell polarity proteins during HNF-4alpha-induced epithelial polarization. 2005, Pubmed
Scheiermann, Junctional adhesion molecule-C mediates leukocyte infiltration in response to ischemia reperfusion injury. 2009, Pubmed
Scheiermann, Expression and function of junctional adhesion molecule-C in myelinated peripheral nerves. 2007, Pubmed
Schmitz, Altered tight junction structure contributes to the impaired epithelial barrier function in ulcerative colitis. 1999, Pubmed
Schulzke, Epithelial transport and barrier function in occludin-deficient mice. 2005, Pubmed
Serhan, Resolvins and protectins in inflammation resolution. 2011, Pubmed
Severson, Junctional adhesion molecule A interacts with Afadin and PDZ-GEF2 to activate Rap1A, regulate beta1 integrin levels, and enhance cell migration. 2009, Pubmed
Severson, Cis-dimerization mediates function of junctional adhesion molecule A. 2008, Pubmed
Shao, JAM-A is present in mammalian spermatozoa where it is essential for normal motility. 2008, Pubmed
Stecker, Loss of Coxsackie and adenovirus receptor downregulates alpha-catenin expression. 2009, Pubmed
Stefanidakis, Endothelial CD47 interaction with SIRPgamma is required for human T-cell transendothelial migration under shear flow conditions in vitro. 2008, Pubmed
Sugano, Junctional adhesion molecule-A, JAM-A, is a novel cell-surface marker for long-term repopulating hematopoietic stem cells. 2008, Pubmed
Sumagin, Transmigrated neutrophils in the intestinal lumen engage ICAM-1 to regulate the epithelial barrier and neutrophil recruitment. 2014, Pubmed
Suzuki, aPKC kinase activity is required for the asymmetric differentiation of the premature junctional complex during epithelial cell polarization. 2002, Pubmed
Tajima, Roles of immunoglobulin-like loops of junctional cell adhesion molecule 4; involvement in the subcellular localization and the cell adhesion. 2003, Pubmed
Tanaka-Okamoto, Involvement of afadin in barrier function and homeostasis of mouse intestinal epithelia. 2011, Pubmed
Tomko, HCAR and MCAR: the human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses. 1997, Pubmed
Tomko, Expression of the adenovirus receptor and its interaction with the fiber knob. 2000, Pubmed
Tsukita, Multifunctional strands in tight junctions. 2001, Pubmed
Utech, Mechanism of IFN-gamma-induced endocytosis of tight junction proteins: myosin II-dependent vacuolarization of the apical plasma membrane. 2005, Pubmed
Van Der Werf, CLMP is required for intestinal development, and loss-of-function mutations cause congenital short-bowel syndrome. 2012, Pubmed
Van Itallie, Claudins and epithelial paracellular transport. 2006, Pubmed
Vetrano, Unique role of junctional adhesion molecule-a in maintaining mucosal homeostasis in inflammatory bowel disease. 2008, Pubmed
Vigl, Coxsackie- and adenovirus receptor (CAR) is expressed in lymphatic vessels in human skin and affects lymphatic endothelial cell function in vitro. 2009, Pubmed
Vincent, Cytokine-mediated downregulation of coxsackievirus-adenovirus receptor in endothelial cells. 2004, Pubmed
Vonlaufen, The role of junctional adhesion molecule C (JAM-C) in acute pancreatitis. 2006, Pubmed
Wang, Interferon-gamma and tumor necrosis factor-alpha synergize to induce intestinal epithelial barrier dysfunction by up-regulating myosin light chain kinase expression. 2005, Pubmed
Wang, The second loop of occludin is required for suppression of Raf1-induced tumor growth. 2005, Pubmed
Wegmann, Endothelial adhesion molecule ESAM binds directly to the multidomain adaptor MAGI-1 and recruits it to cell contacts. 2004, Pubmed
Wegmann, ESAM supports neutrophil extravasation, activation of Rho, and VEGF-induced vascular permeability. 2006, Pubmed
Williams, The immunoglobulin superfamily--domains for cell surface recognition. 1988, Pubmed
Witherden, The junctional adhesion molecule JAML is a costimulatory receptor for epithelial gammadelta T cell activation. 2010, Pubmed
Wojcikiewicz, LFA-1 binding destabilizes the JAM-A homophilic interaction during leukocyte transmigration. 2009, Pubmed
Wong, A synthetic peptide corresponding to the extracellular domain of occludin perturbs the tight junction permeability barrier. 1997, Pubmed , Xenbase
Woodfin, Endothelial cell activation leads to neutrophil transmigration as supported by the sequential roles of ICAM-2, JAM-A, and PECAM-1. 2009, Pubmed
Woodfin, The junctional adhesion molecule JAM-C regulates polarized transendothelial migration of neutrophils in vivo. 2011, Pubmed
Woodfin, JAM-A mediates neutrophil transmigration in a stimulus-specific manner in vivo: evidence for sequential roles for JAM-A and PECAM-1 in neutrophil transmigration. 2007, Pubmed
Yang, Intestinal intraepithelial lymphocyte gamma delta-T cell-derived keratinocyte growth factor modulates epithelial growth in the mouse. 2004, Pubmed
Yokota, The endothelial antigen ESAM marks primitive hematopoietic progenitors throughout life in mice. 2009, Pubmed
Zen, Neutrophil migration across tight junctions is mediated by adhesive interactions between epithelial coxsackie and adenovirus receptor and a junctional adhesion molecule-like protein on neutrophils. 2005, Pubmed
Zen, CD11b/CD18-dependent interactions of neutrophils with intestinal epithelium are mediated by fucosylated proteoglycans. 2002, Pubmed
de Vries, Signal-regulatory protein alpha-CD47 interactions are required for the transmigration of monocytes across cerebral endothelium. 2002, Pubmed
van Raaij, Dimeric structure of the coxsackievirus and adenovirus receptor D1 domain at 1.7 A resolution. 2000, Pubmed